Most experts expect the consolidation to continue in the Nifty 50 as long as it sustains below 25,250. If it crosses above ...

After rebounding from the March 2025 lows, the Nifty50 has regained upward momentum. According to smallcase managers, the ...

RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.

Investing.com-- Most Asian stocks kept to a tight range on Tuesday amid growing caution over U.S. trade tariffs as an August ...

Indian markets may open higher as GIFT Nifty rises and key sectors show momentum. Track live updates and market cues now!

Sumeet Bagadia, executive director of Choice Broking, recommended buying two stocks on Tuesday, July 22, after the Nifty ...

SEBI is considering shifting to fortnightly derivatives expiry to curb expiry-day speculation and protect investors. With ...

With no price-moving triggers visible currently—think tariffs, fresh wars—and earnings mostly in line with expectations, traders have perched themselves on the fence, leading to lower volumes and a ...

Added Protection and Tax Efficiency: When availed through PNB MetLife ULIP Plans, the fund offers life cover of up to 10 times the annualized premium, along with tax-free maturity benefits (applicable ...

Sell-side analysts in India outperform other markets, with a long-short strategy yielding 105% over a decade, highlighting market inefficiencies.

Broader Asian markets were also largely upbeat on Monday, after a mixed performance over the past week. South Korea’s KOSPI ...

Indian equities ended the week lower, with the Nifty slipping 0.7%. On Friday, it declined 143 points to close at 24,968.